, , ,
doi.org/10.1093/annonc/mdg491, hdl.handle.net/1765/71024
Annals of Oncology
Department of Neurology

van den Bent, M.J, Grisold, W, Frappaz, D, Stupp, R, Desir, J.P, Lesimple, T, … Fumoleau, P. (2003). European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme. Annals of Oncology, 14(12), 1732–1734. doi:10.1093/annonc/mdg491